What is the P/S ratio for Aprea Therapeutics, Inc. (APRE)?

The P/S ratio for APRE stock is N/A.

What is the estimated TTM average P/S ratio for Aprea Therapeutics, Inc. (APRE)?

The estimated TTM average P/S ratio for APRE stock is 13.71.

What is the estimated 3Y average P/S ratio for Aprea Therapeutics, Inc. (APRE)?

The estimated 3Y average P/S ratio for APRE stock is 21.23.

Aprea Therapeutics (APRE) Price/Sales Ratio: History & Chart

Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

The P/S ratio is N/A as of 2026-10-06T16:21:09.052Z.

Stored calculation inputs

Calculation as of: 2026-10-06T16:21:09.052Z.

Quote observation: 2026-10-06T16:20:48.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 8,048,804
TTM revenue · period ending 2026-06-30: 0

FMP input reference: d88ebff11657cb0645ea93f74423bc241bf41286751ec96f31399ab1bd3406dc

P/E Ratio|Gross Margin|Revenue Growth|All Metrics

APRE PS Ratio Metrics

PS RATIO

N/A

PS RATIO AVG TTM

13.71

PS RATIO AVG 3Y

21.23

PS RATIO AVG 5Y

N/A

PS RATIO AVG 10Y

N/A

PS RATIO AVG 15Y

N/A

PS RATIO AVG 20Y

N/A

CURRENT VS TTM AVG

N/A

CURRENT VS 3Y AVG

N/A

CURRENT VS 5Y AVG

N/A

CURRENT VS 10Y AVG

N/A

CURRENT VS 15Y AVG

N/A

CURRENT VS 20Y AVG

N/A

APRE Competitors' PS Ratio

APRE

Aprea Therapeutics, Inc.

Current

Market Cap

$8.05M

PS Ratio

N/A

TTM Avg

13.71

3Y Avg

21.23

5Y Avg

N/A

HSCS

HeartSciences Inc.

vs APRE

Market Cap

$8.11M

PS Ratio

N/A

TTM Avg

795.02

3Y Avg

643.34

5Y Avg

689.54

NDRA

ENDRA Life Sciences Inc.

vs APRE

Market Cap

$7.96M

PS Ratio

N/A

TTM Avg

1162916.20

3Y Avg

640325.60

5Y Avg

640325.60

GTBP

GT Biopharma, Inc.

vs APRE

Market Cap

$7.86M

PS Ratio

N/A

TTM Avg

851.62

3Y Avg

851.62

5Y Avg

851.62

MEDS

DataMEDS AI, Inc.

vs APRE

Market Cap

$8.34M

PS Ratio

1.04

TTM Avg

0.68

3Y Avg

1.19

5Y Avg

1.19

HCTI

Healthcare Triangle, Inc.

vs APRE

Market Cap

$8.53M

PS Ratio

0.33

TTM Avg

0.20

3Y Avg

0.21

5Y Avg

0.26

QNCX

Quince Therapeutics, Inc.

vs APRE

Market Cap

$7.71M

PS Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

LGVN

Longeveron Inc.

vs APRE

Market Cap

$7.36M

PS Ratio

6.20

TTM Avg

12.07

3Y Avg

14.45

5Y Avg

39.63

INM

InMed Pharmaceuticals Inc.

vs APRE

Market Cap

$7.31M

PS Ratio

0.00

TTM Avg

0.95

3Y Avg

0.61

5Y Avg

3.52

CNSP

CNS Pharmaceuticals, Inc.

vs APRE

Market Cap

$7.29M

PS Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	PS RATIO	TTM	3Y	5Y
Aprea Therapeutics, Inc. (APRE)	$8.05M	N/A	13.71	21.23	N/A
HeartSciences Inc. (HSCS)vs ›	$8.11M	N/A	795.02	643.34	689.54
ENDRA Life Sciences Inc. (NDRA)vs ›	$7.96M	N/A	1162916.20	640325.60	640325.60
GT Biopharma, Inc. (GTBP)vs ›	$7.86M	N/A	851.62	851.62	851.62
DataMEDS AI, Inc. (MEDS)vs ›	$8.34M	1.04	0.68	1.19	1.19
Healthcare Triangle, Inc. (HCTI)vs ›	$8.53M	0.33	0.20	0.21	0.26
Quince Therapeutics, Inc. (QNCX)vs ›	$7.71M	N/A	N/A	N/A	N/A
Longeveron Inc. (LGVN)vs ›	$7.36M	6.20	12.07	14.45	39.63
InMed Pharmaceuticals Inc. (INM)vs ›	$7.31M	0.00	0.95	0.61	3.52
CNS Pharmaceuticals, Inc. (CNSP)vs ›	$7.29M	N/A	N/A	N/A	N/A

Revenue calculation and filing references
Fiscal period	Revenue	Source
Q3 FY2025Period ended 2025-09-30	$0	Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-12
Q4 FY2025Period ended 2025-12-31	$0	Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-16
Q1 FY2026Period ended 2026-03-31	$0	Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-13
Q2 FY2026Period ended 2026-06-30	$0	Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-12
TTM revenue	$0

Sales Valuation

P/S Ratio

N/A

Market Cap / Trailing Twelve-Month Revenue

PS Ratio Formula & Definition

PS Ratio = Market Cap / Revenue (TTM)

The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

PS Ratio FAQ

What is the P/S ratio for Aprea Therapeutics, Inc. (APRE)?: The P/S ratio for APRE stock is N/A.
What is the estimated TTM average P/S ratio for Aprea Therapeutics, Inc. (APRE)?: The estimated TTM average P/S ratio for APRE stock is 13.71.
What is the estimated 3Y average P/S ratio for Aprea Therapeutics, Inc. (APRE)?: The estimated 3Y average P/S ratio for APRE stock is 21.23.

APRE PS Ratio History

DATE	PS RATIO
2026-08-12	84.92
2026-08-11	82.07
2026-08-10	80.11
2026-08-07	80.86
2026-08-06	78.64
2026-08-05	77.22
2026-08-04	74.51
2026-08-03	74.32
2026-07-31	77.09
2026-07-30	78.95
2026-07-29	77.21
2026-07-28	76.30
2026-07-27	77.67
2026-07-24	78.58
2026-07-23	78.46
2026-07-22	82.06
2026-07-21	81.07
2026-07-20	83.18
2026-07-17	88.22
2026-07-16	85.79
2026-07-15	86.76
2026-07-14	90.57
2026-07-13	89.77
2026-07-10	92.63
2026-07-09	90.52
2026-07-08	92.29
2026-07-07	95.73
2026-07-06	93.25
2026-07-02	92.13
2026-07-01	92.64
2026-06-30	99.75
2026-06-29	101.83
2026-06-26	98.23
2026-06-25	98.21
2026-06-24	100.50
2026-06-23	102.95
2026-06-22	98.67
2026-06-18	88.90
2026-06-17	96.96
2026-06-16	90.68
2026-06-15	86.86
2026-06-12	85.31
2026-06-11	95.12
2026-06-10	93.86
2026-06-09	91.82
2026-06-08	91.30
2026-06-05	92.18
2026-06-04	96.40
2026-06-03	94.74
2026-06-02	95.02
2026-06-01	101.45
2026-05-29	110.98
2026-05-28	115.69
2026-05-27	113.72
2026-05-26	113.15
2026-05-22	118.12
2026-05-21	115.63
2026-05-20	111.89
2026-05-19	99.47
2026-05-18	105.09
2026-05-15	115.64
2026-05-14	117.00
2026-05-13	24.11
2026-05-12	24.66
2026-05-11	25.49
2026-05-08	26.85
2026-05-07	24.13
2026-05-06	22.84
2026-05-05	23.10
2026-05-04	23.04
2026-05-01	22.41
2026-04-30	21.92
2026-04-29	22.44
2026-04-28	22.93
2026-04-27	23.59
2026-04-24	25.48
2026-04-23	24.23
2026-04-22	26.03
2026-04-21	24.86
2026-04-20	26.88
2026-04-17	27.40
2026-04-16	24.87
2026-04-15	25.84
2026-04-14	25.78
2026-04-13	23.21
2026-04-10	25.12
2026-04-09	20.11
2026-04-08	19.22
2026-04-07	19.48
2026-04-06	19.16
2026-04-02	19.60
2026-04-01	19.28
2026-03-31	20.90
2026-03-30	20.25
2026-03-27	18.71
2026-03-26	19.18
2026-03-25	18.39
2026-03-24	18.46
2026-03-23	18.69
2026-03-20	20.88
2026-03-19	20.92
2026-03-18	20.03
2026-03-17	21.43
2026-03-16	9.91
2026-03-13	9.64
2026-03-12	10.02
2026-03-11	10.31
2026-03-10	10.89
2026-03-09	11.07
2026-03-06	11.79
2026-03-05	12.08
2026-03-04	11.92
2026-03-03	11.12
2026-03-02	11.60
2026-02-27	12.01
2026-02-26	11.53
2026-02-25	11.46
2026-02-24	10.48
2026-02-23	10.68
2026-02-20	9.93
2026-02-19	10.72
2026-02-18	9.54
2026-02-17	7.86
2026-02-13	7.98
2026-02-12	7.77
2026-02-11	8.04
2026-02-10	8.39
2026-02-09	8.65
2026-02-06	9.04
2026-02-05	8.18
2026-02-04	8.78
2026-02-03	8.82
2026-02-02	9.84
2026-01-30	10.43
2026-01-29	7.73
2026-01-28	10.01
2026-01-27	10.86
2026-01-26	10.74
2026-01-23	10.88
2026-01-22	11.03
2026-01-21	10.90
2026-01-20	11.47
2026-01-16	11.66
2026-01-15	11.71
2026-01-14	11.79
2026-01-13	11.83
2026-01-12	12.05
2026-01-09	12.38
2026-01-08	12.32
2026-01-07	11.79
2026-01-06	11.95
2026-01-05	11.51
2026-01-02	11.18
2025-12-31	11.18
2025-12-30	11.66
2025-12-29	12.06
2025-12-26	12.84
2025-12-24	12.46
2025-12-23	12.47
2025-12-22	12.20
2025-12-19	12.19
2025-12-18	11.92
2025-12-17	11.93
2025-12-16	11.94
2025-12-15	12.12
2025-12-12	12.25
2025-12-11	12.38
2025-12-10	11.95
2025-12-09	12.16
2025-12-08	13.63
2025-12-05	13.89
2025-12-04	13.89
2025-12-03	13.50
2025-12-02	13.36
2025-12-01	14.54
2025-11-28	16.51
2025-11-26	16.38
2025-11-25	15.85
2025-11-24	15.33
2025-11-21	15.33
2025-11-20	14.54
2025-11-19	15.72
2025-11-18	15.59
2025-11-17	15.59
2025-11-14	15.85
2025-11-13	15.59
2025-11-12	9.11
2025-11-11	9.55
2025-11-10	9.19
2025-11-07	8.90
2025-11-06	8.68
2025-11-05	9.48
2025-11-04	9.91
2025-11-03	10.13
2025-10-31	10.13
2025-10-30	10.49
2025-10-29	10.49
2025-10-28	10.27
2025-10-27	9.69
2025-10-24	10.13
2025-10-23	10.99
2025-10-22	11.07
2025-10-21	10.92
2025-10-20	11.94
2025-10-17	11.36
2025-10-16	11.14
2025-10-15	10.78
2025-10-14	10.92
2025-10-13	10.63
2025-10-10	10.27
2025-10-09	10.71
2025-10-08	10.34
2025-10-07	10.42
2025-10-06	10.78
2025-10-03	10.85
2025-10-02	10.71
2025-10-01	10.56
2025-09-30	10.71
2025-09-29	10.92
2025-09-26	10.56
2025-09-25	10.42
2025-09-24	10.27
2025-09-23	10.42
2025-09-22	10.63
2025-09-19	10.42
2025-09-18	10.85
2025-09-17	10.85
2025-09-16	10.56
2025-09-15	10.92
2025-09-12	11.14
2025-09-11	11.36
2025-09-10	11.21
2025-09-09	11.21
2025-09-08	11.65
2025-09-05	11.21
2025-09-04	10.85
2025-09-03	11.07
2025-09-02	11.36
2025-08-29	11.36
2025-08-28	11.50
2025-08-27	11.57
2025-08-26	11.43
2025-08-25	11.57
2025-08-22	11.94
2025-08-21	11.57
2025-08-20	11.36
2025-08-19	11.50
2025-08-18	11.94
2025-08-15	12.22
2025-08-14	12.22
2025-08-13	12.37
2025-08-12	7.93
2025-08-11	7.89
2025-08-08	7.93
2025-08-07	7.70
2025-08-06	7.65
2025-08-05	8.35
2025-08-04	7.93
2025-08-01	7.75
2025-07-31	7.93

Showing the most recent 260 of 753 data points. The chart above shows the full history.

PS Ratio: N/A

APRE PS Ratio Chart

APRE Average PS Ratio Chart

APRE PS Ratio Metrics

APRE Competitors' PS Ratio

Sales Valuation

PS Ratio Formula & Definition

PS Ratio FAQ

APRE PS Ratio History

Related Metrics